View source for Pregnenolone

You do not have permission to edit this page, for the following reasons:

This IP address has been blocked from editing Wikipedia.
This does not affect your ability to read Wikipedia pages.
Most people who see this message have done nothing wrong. Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.

The IP address or range 52.87.0.0/16 has been blocked by ‪ST47‬ for the following reason(s):

The IP address that you are currently using has been blocked because it is believed to be a web host provider. To prevent abuse, web hosts may be blocked from editing Wikipedia.
You will not be able to edit Wikipedia using a web host provider because it hides your IP address, much like a proxy or VPN.
We recommend that you attempt to use another connection to edit. For example, if you use a proxy or VPN to connect to the internet, turn it off when editing Wikipedia. If you edit using a mobile connection, try using a Wi-Fi connection, and vice versa. If you are using a corporate internet connection, switch to a different Wi-Fi network. If you have a Wikipedia account, please log in.
If you do not have any other way to edit Wikipedia, you will need to request an IP block exemption.

How to appeal if you are confident that your connection does not use a web host's IP address:
If you are confident that you are not using a web host, you may appeal this block by adding the following text on your talk page: {{unblock|reason=Caught by a web host block but this host or IP is not a web host. My IP address is _______. Place any further information here. ~~~~}}. You must fill in the blank with your IP address for this block to be investigated. Your IP address can be determined here. Alternatively, if you wish to keep your IP address private you can use the unblock ticket request system. There are several reasons you might be editing using the IP address of a web host (such as if you are using VPN software or a business network); please use this method of appeal only if you think your IP address is in fact not a web host.

Administrators: The IP block exemption user right should only be applied to allow users to edit using web host in exceptional circumstances, and they should usually be directed to the functionaries team via email. If you intend to give the IPBE user right, a CheckUser needs to take a look at the account. This can be requested most easily at SPI Quick Checkuser Requests. Unblocking an IP or IP range with this template is highly discouraged without at least contacting the blocking administrator.

This block will expire on 07:33, 6 August 2027. Your current IP address is 52.87.161.36.

Even when blocked, you will usually still be able to edit your user talk page, as well as email administrators and other editors.

For information on how to proceed, please read the FAQ for blocked users and the guideline on block appeals. The guide to appealing blocks may also be helpful.

Other useful links: Blocking policy · Help:I have been blocked
This IP address range has been globally blocked.
This does not affect your ability to read Wikipedia pages.
Most people who see this message have done nothing wrong. Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.

This block affects editing on all Wikimedia wikis.
The IP address or range 52.87.0.0/16 has been globally blocked by ‪Jon Kolbert‬ for the following reason(s):

Open proxy/Webhost: See the help page if you are affected

This block will expire on 05:39, 21 February 2029. Your current IP address is 52.87.161.36.

Even while globally blocked, you will usually still be able to edit pages on Meta-Wiki.

If you believe you were blocked by mistake, you can find additional information and instructions in the No open proxies global policy. Otherwise, to discuss the block please post a request for review on Meta-Wiki. You could also send an email to the stewards VRT queue at stewards@wikimedia.org including all above details.

Other useful links: Global blocks · Help:I have been blocked

You can view and copy the source of this page:

{{Distinguish|Pregnanolone|Pregneninolone}}
{{About|pregnenolone as a hormone|its use as a medication or supplement|Pregnenolone (medication)}}
{{Chembox
<!-- Images -->
| ImageFile = Pregnenolone.svg
| ImageSize = 235px
| ImageFile2 = Pregnenolona3D.png
| ImageSize2 = 235px
<!-- Names -->
| IUPACName = 3β-Hydroxypregn-5-en-20-one
| SystematicName = 1-[(1''S'',3a''S'',3b''S'',7''S'',9a''R'',9b''S'',11a''S'')-7-Hydroxy-9a,11a-dimethyl-2,3,3a,3b,4,6,7,8,9,9a,9b,10,11,11a-tetradecahydro-1''H''-cyclopenta[''a'']phenanthren-1-yl]ethan-1-one
| OtherNames = P5; 5-Pregnenolone; δ<sup>5</sup>-Pregnene-3β-ol-20-one; Pregn-5-en-3β-ol-20-one; NSC-1616
<!-- Sections -->
| Section1 = {{Chembox Identifiers
| CASNo = 145-13-1
| ChEBI = 16581
| ChEMBL = 253363
| ChemSpiderID = 8611
| DrugBank = DB02789
| KEGG = C01953
| PubChem = 8955
| SMILES = CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C
| StdInChI = 1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1
| StdInChIKey = ORNBQBCIOKFOEO-QGVNFLHTSA-N
| UNII = 73R90F7MQ8
  }}
| Section2 = {{Chembox Properties
| C=21 | H=32 | O=2
| MolarMass = 316.485 g/mol
| Appearance = 
| Density = 
| MeltingPt = 193 °C
| BoilingPt = 
| Solubility = 
  }}
| Section3 = {{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt =
  }}
}}

'''Pregnenolone''' ('''P5'''), or '''pregn-5-en-3β-ol-20-one''', is an [[endogenous]] [[steroid]] and [[precursor (biochemistry)|precursor]]/[[metabolic intermediate]] in the [[biosynthesis]] of most of the [[steroid hormone]]s, including the [[progestogen]]s, [[androgen]]s, [[estrogen]]s, [[glucocorticoid]]s, and [[mineralocorticoid]]s.<ref name="pmid15415436">{{cite journal | vauthors = Henderson E, Weinberg M, Wright WA | title = Pregnenolone | journal = J. Clin. Endocrinol. Metab. | volume = 10 | issue = 4 | pages = 455–74 | date = April 1950 | pmid = 15415436 | doi = 10.1210/jcem-10-4-455 }}</ref> In addition, pregnenolone is [[biological activity|biologically active]] in its own right, acting as a [[neurosteroid]].<ref name="pmid21756978"/>

In addition to its role as a natural hormone, pregnenolone has been used as a [[medication]] and [[dietary supplement|supplement]]; for information on pregnenolone as a medication or supplement, see the [[pregnenolone (medication)]] article.

{{TOC limit|3}}

==Biological function==
Pregnenolone and its 3β-[[sulfate]], pregnenolone sulfate, like DHEA, [[DHEA sulfate]], and progesterone, belong to the group of [[neuroactive steroid|neurosteroid]]s that are found in high concentrations in certain areas of the brain, and are synthesized there. Neurosteroids affect synaptic functioning, are [[neuroprotective]], and enhance [[myelin]]ization. Pregnenolone and its sulfate ester may improve cognitive and [[memory]] function.<ref name="pmid11744095">{{cite journal |vauthors=Vallée M, Mayo W, Le Moal M | title = Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging | journal = Brain Research. Brain Research Reviews | volume = 37 | issue = 1–3 | pages = 301–12 |date=November 2001 | pmid = 11744095 | doi = 10.1016/S0165-0173(01)00135-7| s2cid = 22186709 }}</ref> In addition, they may have protective effects against [[schizophrenia]].<ref name="pmid21756978">{{cite journal  |vauthors=Marx CE, Bradford DW, Hamer RM, etal | title = Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence | journal = Neuroscience | volume = 191 | pages = 78–90 |date=September 2011 | pmid = 21756978 | doi = 10.1016/j.neuroscience.2011.06.076 | s2cid = 26396652 }}</ref>

==Biological activity==

===Neurosteroid activity===
Pregnenolone is an allosteric [[endocannabinoid]], as it is a [[negative allosteric modulator]] of the [[CB1 receptor|CB<sub>1</sub> receptor]].<ref name="pmid26433186" /><ref name="Pertwee2015">{{Citation|last=Pertwee|first=Roger G.|date=2015|pages=1–37|publisher=Springer International Publishing|language=en|doi=10.1007/978-3-319-20825-1_1|pmid=26408156|isbn=9783319208244|title=Endocannabinoids|volume=231|series=Handbook of Experimental Pharmacology|chapter=Endocannabinoids and Their Pharmacological Actions}}</ref> Pregnenolone is involved in a natural [[negative feedback]] loop against CB<sub>1</sub> receptor activation in animals. It prevents CB<sub>1</sub> receptor [[agonist]]s like [[tetrahydrocannabinol]], the main active constituent in [[cannabis (drug)|cannabis]], from fully activating the CB<sub>1</sub>.<ref>Vallée, M., Vitiello, S., Bellocchio, L., Hébert-Chatelain, E., Monlezun, S., Martin-Garcia, E., Kasanetz, F., Baillie, GL., Panin, F., Cathala, A., Roullot-Lacarrière, V., Fabre, S., Hurst, DP., Lynch, DL., Shore, DM., Deroche-Gamonet, V., Spampinato, U., Revest, JM., Maldonado, R., Reggio, PH., Ross, RA., Marsicano, G., Piazza, PV. [https://www.researchgate.net/publication/259567046], "Pregnenolone Can Protect the Brain from Cannabis Intoxication", ''Science'', January 2014 Science 343(6166):94-8.</ref> A related compound [[AEF0117]] has been derived from pregnenolone and is more specific for this type of activity.

Pregnenolone has been found to bind with high, [[nanomolar]] [[affinity (pharmacology)|affinity]] to [[microtubule-associated protein 2]] (MAP2) in the brain.<ref name="pmid17651807">{{cite journal | vauthors = Mellon SH | title = Neurosteroid regulation of central nervous system development | journal = Pharmacol. Ther. | volume = 116 | issue = 1 | pages = 107–24 | year = 2007 | pmid = 17651807 | pmc = 2386997 | doi = 10.1016/j.pharmthera.2007.04.011 }}</ref><ref name="pmid16537405">{{cite journal | vauthors = Fontaine-Lenoir V, Chambraud B, Fellous A, David S, Duchossoy Y, Baulieu EE, Robel P | title = Microtubule-associated protein 2 (MAP2) is a neurosteroid receptor | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 103 | issue = 12 | pages = 4711–6 | year = 2006 | pmid = 16537405 | pmc = 1450236 | doi = 10.1073/pnas.0600113103 | bibcode = 2006PNAS..103.4711F | doi-access = free }}</ref> In contrast to pregnenolone, pregnenolone sulfate did not bind to [[microtubule]]s.<ref name="pmid17651807" /><ref name="pmid16537405" /> However, progesterone did and with similar affinity to pregnenolone, although unlike pregnenolone, it did not increase binding of MAP2 to [[tubulin]].<ref name="pmid17651807" /><ref name="pmid16537405" /> Pregnenolone was found to induce tubule polymerization in neuronal cultures and to increase [[neurite]] growth in PC12 cells treated with [[nerve growth factor]].<ref name="pmid17651807" /><ref name="pmid16537405" /> As such, pregnenolone may control formation and stabilization of microtubules in neurons and may affect both [[neural development]] during [[prenatal development]] and [[neural plasticity]] during [[aging]].<ref name="pmid17651807" /><ref name="pmid16537405" />

Although pregnenolone itself does not possess these activities, its [[metabolite]] [[pregnenolone sulfate]] is a [[negative allosteric modulator]] of the [[GABAA receptor|GABA<sub>A</sub> receptor]]<ref name="pmid3138576">{{cite journal |vauthors=Majewska MD, Mienville JM, Vicini S | title = Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons | journal = Neuroscience Letters | volume = 90 | issue = 3 | pages = 279–84 |date=August 1988 | pmid = 3138576 | doi = 10.1016/0304-3940(88)90202-9| s2cid = 1101046 }}</ref> as well as a [[positive allosteric modulator]] of the [[NMDA receptor]].<ref name="pmid1654510">{{cite journal |vauthors=Wu FS, Gibbs TT, Farb DH | title = Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor | journal = Molecular Pharmacology | volume = 40 | issue = 3 | pages = 333–6 |date=September 1991 | pmid = 1654510 | url = http://molpharm.aspetjournals.org/cgi/pmidlookup?view=long&pmid=1654510}}</ref><ref name="pmid1387199">{{cite journal |vauthors=Irwin RP, Maragakis NJ, Rogawski MA, Purdy RH, Farb DH, Paul SM | title =  Pregnenolone sulfate augments NMDA receptor mediated increases in intracellular Ca2+ in cultured rat hippocampal neurons | journal = Neurosci Lett | volume = 141 | issue = 1 |pages = 30–4 | date = July 1992 |pmid =1387199 | doi=10.1016/0304-3940(92)90327-4| s2cid = 36972583 | url = https://zenodo.org/record/1258463 }}</ref> In addition, pregnenolone sulfate has been shown to activate the [[TRPM3|transient receptor potential M3]] (TRPM3) [[ion channel]] in [[hepatocyte]]s and [[Islets of Langerhans|pancreatic islet]]s causing [[calcium]] entry and subsequent [[insulin]] release.<ref name="pmid18978782">{{cite journal  |vauthors=Wagner TF, Loch S, Lambert S, etal | title = Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells | journal = Nature Cell Biology | volume = 10 | issue = 12 | pages = 1421–30 |date=December 2008 | pmid = 18978782 | doi = 10.1038/ncb1801 | s2cid = 19925356 }}</ref>

===Nuclear receptor activity===
Pregnenolone has been found to act as an [[agonist]] of the [[pregnane X receptor]].<ref name="pmid10548883">{{cite journal | vauthors = Kliewer SA, Lehmann JM, Milburn MV, Willson TM | title = The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways | journal = Recent Prog. Horm. Res. | volume = 54 | pages = 345–67; discussion 367–8 | year = 1999 | pmid = 10548883 }}</ref>

Pregnenolone has no [[progestogen]]ic, [[corticosteroid]], [[estrogen]]ic, [[androgen]]ic, or [[antiandrogen]]ic activity.<ref name="pmid15415436" />

==Biochemistry==
[[File:Steroidogenesis.svg|right|thumb|450px|[[Steroidogenesis]], showing pregnenolone near top left]]

===Biosynthesis===
Pregnenolone is [[biosynthesis|synthesized]] from [[cholesterol]]. This [[biotransformation|conversion]] involves [[hydroxylation]] of the [[side chain]] at the C20 and C22 positions, with [[bond cleavage|cleavage]] of the [[side chain]]. The [[enzyme]] performing this task is [[P450scc|cytochrome P450scc]], located in the [[mitochondria]],<ref name="1981-Hanukoglu-2">{{cite journal |vauthors=Hanukoglu I, Spitsberg V, Bumpus JA, Dus KM, Jefcoate CR |title=Adrenal mitochondrial cytochrome P-450scc. Cholesterol and Adirondacks interactions at equilibrium and during turnover |journal=J Biol Chem |volume=256 |issue=9 |pages=4321–8 |date=May 1981 |pmid=7217084 |doi=10.1016/S0021-9258(19)69436-6 |url=|doi-access=free }}</ref> and controlled by [[anterior pituitary]] [[trophic hormone]]s, such as [[adrenocorticotropic hormone]], [[follicle-stimulating hormone]], and [[luteinizing hormone]], in the [[adrenal gland]]s and [[gonad]]s.<ref name="1990-Hanukoglu">{{cite journal |vauthors=Hanukoglu I, Feuchtwanger R, Hanukoglu A |title=Mechanism of corticotropin and cAMP induction of mitochondrial cytochrome P450 system enzymes in adrenal cortex cells |journal=J Biol Chem |volume=265 |issue=33 |pages=20602–8 |date=November 1990 |pmid=2173715 |doi=10.1016/S0021-9258(17)30545-8 |doi-access=free |url=}}</ref> There are two [[metabolic intermediate|intermediate]]s in the transformation of cholesterol into pregnenolone, [[22R-hydroxycholesterol|22''R''-hydroxycholesterol]] and [[20α,22R-dihydroxycholesterol|20α,22''R''-dihydroxycholesterol]], and all three steps in the transformation are catalyzed by P450scc.<ref name="LemkeWilliams2008">{{cite book|author1=Thomas L. Lemke|author2=David A. Williams|title=Foye's Principles of Medicinal Chemistry|url=https://books.google.com/books?id=R0W1ErpsQpkC&pg=PA883|year=2008|publisher=Lippincott Williams & Wilkins|isbn=978-0-7817-6879-5|pages=883–}}</ref> Pregnenolone is produced mainly in the [[adrenal gland]]s, the [[gonad]]s, and the [[brain]].<ref name="pmid26433186">{{cite journal | vauthors = Vallée M | title = Neurosteroids and potential therapeutics: Focus on pregnenolone | journal = J. Steroid Biochem. Mol. Biol. | volume = 160 | pages = 78–87 | year = 2016 | pmid = 26433186 | doi = 10.1016/j.jsbmb.2015.09.030 | s2cid = 3468546 }}</ref> Although pregnenolone is also produced in the gonads and brain, most circulating pregnenolone is derived from the [[adrenal cortex]].<ref name="QuestDiagnostics">{{Cite web |title=The Quest Diagnostics Manual. Endocrinology. Test Selection and Interpretation. Fourth Edition |url=https://docplayer.net/86293048-The-quest-diagnostics-manual-endocrinology-test-selection-and-interpretation-fourth-edition.html |access-date=15 September 2023 |website=docplayer.net |page=152}}</ref>

To assay conversion of cholesterol to pregnenolone, radiolabeled cholesterol has been used.<ref name="HanukogluJefcoate1980">{{cite journal|vauthors=Hanukoglu I, Jefcoate CR | title = Pregnenolone separation from cholesterol using Sephadex LH-20 mini-columns | journal = Journal of Chromatography A | year = 1980 | volume = 190 | issue = 1 | pages = 256–262 | doi = 10.1016/S0021-9673(00)85545-4 | url = https://zenodo.org/record/890904 }}</ref> Pregnenolone product can be separated from cholesterol substrate using Sephadex LH-20 minicolumns.<ref name="HanukogluJefcoate1980" />

===Distribution===
Pregnenolone is [[lipophilic]] and readily crosses the [[blood–brain barrier]].<ref name="pmid23348009">{{cite journal | vauthors = Sripada RK, Marx CE, King AP, Rampton JC, Ho SS, Liberzon I | title = Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits | journal = Biol. Psychiatry | volume = 73 | issue = 11 | pages = 1045–53 | year = 2013 | pmid = 23348009 | pmc = 3648625 | doi = 10.1016/j.biopsych.2012.12.008 }}</ref> This is in contrast to [[pregnenolone sulfate]], which does not cross the blood–brain barrier.<ref name="RhoSankar2010">{{cite book|author1=Jong Rho|author2=Raman Sankar|author3=Carl E. Stafstrom|title=Epilepsy: Mechanisms, Models, and Translational Perspectives|url=https://books.google.com/books?id=8prMBQAAQBAJ&pg=PA479|date=18 June 2010|publisher=CRC Press|isbn=978-1-4200-8560-0|pages=479–}}</ref><ref name="Symposium2008">{{cite book|author=CIBA Foundation Symposium|title=Steroids and Neuronal Activity|url=https://books.google.com/books?id=KeZlL3XbmQsC&pg=PA101|date=30 April 2008|publisher=John Wiley & Sons|isbn=978-0-470-51399-6|pages=101–}}</ref>

===Metabolism===
Pregnenolone undergoes further steroid [[metabolism]] in one of several ways:

* Pregnenolone can be converted into [[progesterone]]. The critical enzyme step is two-fold using a [[3β-hydroxysteroid dehydrogenase]] and a [[delta 5-4 isomerase|Δ<sup>5-4</sup> isomerase]]. The latter transfers the [[double bond]] from C5 to C4 on the A ring.  Progesterone is the entry into the Δ<sup>4</sup> pathway, resulting in production of [[17α-hydroxyprogesterone]] and [[androstenedione]], precursor to [[testosterone]] and [[estrone]]. [[Aldosterone]] and [[corticosteroid]]s are also derived from progesterone or its derivatives.
* Pregnenolone can be converted to [[17α-hydroxypregnenolone]] by the enzyme 17α-hydroxylase ([[CYP17A1]]). Using this pathway, termed Δ<sup>5</sup> pathway, the next step is conversion to [[dehydroepiandrosterone]] (DHEA) via 17,20-lyase (CYP17A1). DHEA is the precursor of androstenedione.
* Pregnenolone can be converted to [[androstadienol]] by 16-ene synthase (CYP17A1).
* Pregnenolone can be converted to [[pregnenolone sulfate]] by [[steroid sulfotransferase]], and this conversion can be reversed by [[steroid sulfatase]].

===Levels===
Normal circulating levels of pregnenolone are as follows:<ref name="QuestDiagnostics" />

* Men: 10 to 200&nbsp;ng/dL
* Women: 10 to 230&nbsp;ng/dL
* Children: 10 to 48&nbsp;ng/dL
* Adolescent boys: 10 to 50&nbsp;ng/dL
* Adolescent girls: 15 to 84&nbsp;ng/dL

Mean levels of pregnenolone have been found not to significantly differ in postmenopausal women and elderly men (40 and 39&nbsp;ng/dL, respectively).<ref name="pmid6274897">{{cite journal | vauthors = Vermeulen A, Deslypere JP, Schelfhout W, Verdonck L, Rubens R | title = Adrenocortical function in old age: response to acute adrenocorticotropin stimulation | journal = J. Clin. Endocrinol. Metab. | volume = 54 | issue = 1 | pages = 187–91 | date = January 1982 | pmid = 6274897 | doi = 10.1210/jcem-54-1-187 }}</ref>

Studies have found that pregnenolone levels are not significantly changed after [[surgical castration|surgical]] or [[medical castration]] in men, which is in accordance with the fact that pregnenolone is mainly derived from the adrenal glands.<ref name="VickeryNestor2012">{{cite book|author1=B.H. Vickery|author2=J.J. Nestor|author3=E.S. Hafez|title=LHRH and Its Analogs: Contraceptive and Therapeutic Applications|url=https://books.google.com/books?id=am3yCAAAQBAJ&pg=PA341|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-009-5588-2|pages=341–|quote=On the other hand there were no significant changes in serum levels of the steroid precursors pregnenolone and progesterone. [...] Unchanged levels of pregnenolone, in the presence of decreased 17α-OH-progesterone and testosterone concentrations, suggest that a block of 17-hydroxylase and 17,20-desmolase activity takes place in the human testis.}}</ref><ref name="pmid6086697">{{cite journal | vauthors = Bélanger A, Dupont A, Labrie F | title = Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer | journal = J. Clin. Endocrinol. Metab. | volume = 59 | issue = 3 | pages = 422–6 | date = September 1984 | pmid = 6086697 | doi = 10.1210/jcem-59-3-422 }}</ref><ref name="pmid6800852">{{cite journal | vauthors = Faure N, Labrie F, Lemay A, Bélanger A, Gourdeau Y, Laroche B, Robert G | title = Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men | journal = Fertil. Steril. | volume = 37 | issue = 3 | pages = 416–24 | date = March 1982 | pmid = 6800852 | doi = 10.1016/S0015-0282(16)46107-8 | doi-access = free }}</ref> Conversely, medical castration has been found to partially suppress pregnenolone levels in premenopausal women.<ref name="pmid2199228">{{cite journal | vauthors = Dupont A, Dupont P, Belanger A, Mailoux J, Cusan L, Labrie F | title = Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH2(10)]LH-RH ethylamide | journal = Fertil. Steril. | volume = 54 | issue = 2 | pages = 227–32 | date = August 1990 | pmid = 2199228 | doi = 10.1016/S0015-0282(16)53694-2 | doi-access = free }}</ref><ref name="pmid3116031">{{cite journal | vauthors = Steingold K, De Ziegler D, Cedars M, Meldrum DR, Lu JK, Judd HL, Chang RJ | title = Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease | journal = J. Clin. Endocrinol. Metab. | volume = 65 | issue = 4 | pages = 773–8 | date = October 1987 | pmid = 3116031 | doi = 10.1210/jcem-65-4-773 }}</ref> Similarly, an [[adrenalectomy|adrenalectomized]] premenopausal woman showed incompletely diminished circulating pregnenolone levels.<ref name="pmid4270264">{{cite journal | vauthors = Abraham GE, Chakmakjian ZH | title = Serum steroid levels during the menstrual cycle in a bilaterally adrenalectomized woman | journal = J. Clin. Endocrinol. Metab. | volume = 37 | issue = 4 | pages = 581–7 | date = October 1973 | pmid = 4270264 | doi = 10.1210/jcem-37-4-581 }}</ref>

==Chemistry==
{{See also|List of neurosteroids}}

Pregnenolone is also known chemically as pregn-5-en-3β-ol-20-one.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA665|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=665–}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA872|year=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=872–873}}</ref> Like other [[steroid]]s, it consists of four interconnected [[cyclic hydrocarbon]]s.<ref name="Elks2014" /><ref name="IndexNominum2000" /> The compound contains [[ketone]] and [[hydroxyl]] [[functional group]]s, two [[methyl]] branches, and a [[double bond]] at C5, in the B cyclic hydrocarbon ring.<ref name="Elks2014" /><ref name="IndexNominum2000" /> Like many steroid hormones, it is [[hydrophobic]]. The [[sulfated]] derivative, [[pregnenolone sulfate]], is water-soluble.

[[3β-Dihydroprogesterone]] (pregn-4-en-3β-ol-20-one) is an [[isomer]] of pregnenolone in which the C5 [[double bond]] has been replaced with a C4 double bond.<ref name="pmid15415436" />

==History==
Pregnenolone was first [[chemical synthesis|synthesized]] by [[Adolf Butenandt]] and colleagues in 1934.<ref>{{cite journal |last1=Butenandt |first1=Adolf |last2=Westphal |first2=Ulrich |last3=Cobler |first3=Heinz |title=Über einen Abbau des Stigmasterins zu corpus-luteum-wirksamen Stoffen; ein Beitrag zur Konstitution des Corpusluteum-Hormons (Vorläuf. Mitteil.) |journal=Berichte der Deutschen Chemischen Gesellschaft (A and B Series) |date=12 September 1934 |volume=67 |issue=9 |pages=1611–1616 |doi=10.1002/cber.19340670931}}</ref>

==References==
{{Reflist}}

{{Endogenous steroids}}
{{Navboxes
| title = [[Biological activity]]
| titlestyle = background:#ccccff
| list1 = 
{{Cannabinoid receptor modulators}}
{{Glycine receptor modulators}}
{{Sigma receptor modulators}}
{{Xenobiotic-sensing receptor modulators}}
}}

[[Category:Sterols]]
[[Category:CB1 receptor antagonists]]
[[Category:Glycine receptor agonists]]
[[Category:Ketones]]
[[Category:Neurosteroids]]
[[Category:Pregnane X receptor agonists]]
[[Category:Pregnanes]]
[[Category:Sigma agonists]]
[[Category:Steroid hormones]]
[[Category:CB1 receptor negative allosteric modulators]]

Pages transcluded onto the current version of this page (help):

Template:Abbr (view source) (protected)
Template:Abbrlink (view source) (template editor protected)
Template:About (view source) (template editor protected)
Template:Button (view source) (template editor protected)
Template:Cannabinoid receptor modulators (edit)
Template:Chembox (view source) (template editor protected)
Template:Chembox/styles.css (view source) (template editor protected)
Template:Chembox 3DMet (view source) (template editor protected)
Template:Chembox 3DMet/format (view source) (template editor protected)
Template:Chembox AllOtherNames (view source) (template editor protected)
Template:Chembox AllOtherNames/format (view source) (template editor protected)
Template:Chembox CASNo (view source) (template editor protected)
Template:Chembox CASNo/format (view source) (template editor protected)
Template:Chembox CalcTemperatures (view source) (template editor protected)
Template:Chembox ChEBI (view source) (template editor protected)
Template:Chembox ChEBI/format (view source) (template editor protected)
Template:Chembox ChEMBL (view source) (template editor protected)
Template:Chembox ChEMBL/format (view source) (template editor protected)
Template:Chembox ChemSpiderID (view source) (template editor protected)
Template:Chembox ChemSpiderID/format (view source) (template editor protected)
Template:Chembox CompTox (view source) (template editor protected)
Template:Chembox CompTox/format (view source) (template editor protected)
Template:Chembox Datapage check (view source) (template editor protected)
Template:Chembox DrugBank (view source) (template editor protected)
Template:Chembox DrugBank/format (view source) (template editor protected)
Template:Chembox ECHA (view source) (template editor protected)
Template:Chembox ECNumber (view source) (template editor protected)
Template:Chembox ECNumber/format (view source) (template editor protected)
Template:Chembox Elements (view source) (template editor protected)
Template:Chembox Elements/molecular formula (view source) (template editor protected)
Template:Chembox Footer (view source) (template editor protected)
Template:Chembox Footer/tracking (view source) (template editor protected)
Template:Chembox Hazards (view source) (template editor protected)
Template:Chembox IUPHAR ligand (view source) (template editor protected)
Template:Chembox IUPHAR ligand/format (view source) (template editor protected)
Template:Chembox Identifiers (view source) (template editor protected)
Template:Chembox InChI (view source) (template editor protected)
Template:Chembox InChI/format (view source) (template editor protected)
Template:Chembox Indexlist (view source) (template editor protected)
Template:Chembox Jmol (view source) (template editor protected)
Template:Chembox Jmol/format (view source) (template editor protected)
Template:Chembox KEGG (view source) (template editor protected)
Template:Chembox KEGG/format (view source) (template editor protected)
Template:Chembox MeltingPt (view source) (template editor protected)
Template:Chembox Properties (view source) (template editor protected)
Template:Chembox PubChem (view source) (template editor protected)
Template:Chembox PubChem/format (view source) (template editor protected)
Template:Chembox RTECS (view source) (template editor protected)
Template:Chembox RTECS/format (view source) (template editor protected)
Template:Chembox SMILES (view source) (template editor protected)
Template:Chembox SMILES/format (view source) (template editor protected)
Template:Chembox UNII (view source) (template editor protected)
Template:Chembox UNII/format (view source) (template editor protected)
Template:Chembox headerbar (view source) (template editor protected)
Template:Chembox image (view source) (template editor protected)
Template:Chembox image cell (view source) (template editor protected)
Template:Chembox image sbs (view source) (template editor protected)
Template:Chembox parametercheck (view source) (template editor protected)
Template:Chembox templatePar/formatPreviewMessage (view source) (template editor protected)
Template:Citation (view source) (protected)
Template:Cite book (view source) (protected)
Template:Cite journal (view source) (protected)
Template:Cite web (view source) (protected)
Template:Collapsible list (view source) (template editor protected)
Template:Distinguish (view source) (template editor protected)
Template:EditAtWikidata (view source) (protected)
Template:Endogenous steroids (edit)
Template:First nonempty (view source) (template editor protected)
Template:Glycine receptor modulators (edit)
Template:Hlist/styles.css (view source) (protected)
Template:If empty (view source) (protected)
Template:Longitem (view source) (template editor protected)
Template:Main other (view source) (protected)
Template:Navbox (view source) (template editor protected)
Template:Navboxes (view source) (template editor protected)
Template:Nobold (view source) (template editor protected)
Template:Nobold/styles.css (view source) (template editor protected)
Template:Pagetype (view source) (protected)
Template:ParmPart (view source) (template editor protected)
Template:Plainlist/styles.css (view source) (protected)
Template:Reflist (view source) (protected)
Template:Reflist/styles.css (view source) (protected)
Template:SDcat (view source) (protected)
Template:See also (view source) (template editor protected)
Template:Short description (view source) (protected)
Template:Short description/lowercasecheck (view source) (protected)
Template:Sigma receptor modulators (edit)
Template:Steroid hormones (edit)
Template:TOC limit (view source) (template editor protected)
Template:TOC limit/styles.css (view source) (template editor protected)
Template:Trim (view source) (protected)
Template:Unbulleted list (view source) (template editor protected)
Template:Xenobiotic-sensing receptor modulators (edit)
Template:Yesno (view source) (protected)
Module:About (view source) (template editor protected)
Module:Arguments (view source) (protected)
Module:Check for unknown parameters (view source) (protected)
Module:Citation/CS1 (view source) (protected)
Module:Citation/CS1/COinS (view source) (protected)
Module:Citation/CS1/Configuration (view source) (protected)
Module:Citation/CS1/Date validation (view source) (protected)
Module:Citation/CS1/Identifiers (view source) (protected)
Module:Citation/CS1/Utilities (view source) (protected)
Module:Citation/CS1/Whitelist (view source) (protected)
Module:Citation/CS1/styles.css (view source) (protected)
Module:Collapsible list (view source) (template editor protected)
Module:Disambiguation/templates (view source) (protected)
Module:Distinguish (view source) (template editor protected)
Module:EditAtWikidata (view source) (protected)
Module:Format link (view source) (template editor protected)
Module:Hatnote (view source) (template editor protected)
Module:Hatnote/styles.css (view source) (template editor protected)
Module:Hatnote list (view source) (template editor protected)
Module:If empty (view source) (protected)
Module:InfoboxImage (view source) (template editor protected)
Module:Labelled list hatnote (view source) (template editor protected)
Module:List (view source) (protected)
Module:Math (view source) (protected)
Module:Navbar (view source) (protected)
Module:Navbar/configuration (view source) (protected)
Module:Navbar/styles.css (view source) (protected)
Module:Navbox (view source) (template editor protected)
Module:Navbox/configuration (view source) (template editor protected)
Module:Navbox/styles.css (view source) (template editor protected)
Module:Navboxes (view source) (template editor protected)
Module:Pagetype (view source) (protected)
Module:Pagetype/config (view source) (protected)
Module:Pagetype/disambiguation (view source) (protected)
Module:Pagetype/rfd (view source) (protected)
Module:Pagetype/setindex (view source) (protected)
Module:Pagetype/softredirect (view source) (protected)
Module:ParameterCount (view source) (template editor protected)
Module:SDcat (view source) (protected)
Module:String (view source) (protected)
Module:TableTools (view source) (protected)
Module:TemplatePar (view source) (template editor protected)
Module:Wikidata (view source) (template editor protected)
Module:Wikitext Parsing (view source) (protected)
Module:Yesno (view source) (protected)

Return to Pregnenolone.

Retrieved from "https://en.wikipedia.org/wiki/Pregnenolone"